Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remeron for Weight Loss in Advanced Cancer
NCT00832520Phase 2Terminated
- Sponsor
- New Mexico Cancer Research Alliance
- Start
- Nov 2008
- Primary completion
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of mirtazapine in cancer cachexia, sponsored by New Mexico Cancer Research Alliance. Primary endpoint: Change in Weight at 8 weeks. Started Nov 2008; status: terminated.
02
Drugs
mirtazapine
03
Conditions
cancer cachexia
Beyond the preview
Go deeper on NCT00832520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00832520.